Albemarle (ALB) Tops Q2 EPS by $2.60; Offers FY23 Guidance
Tweet
Share
E-mail
Get Alerts ALB Hot Sheet
Price: $126.28 -4.45%
EPS Growth %: +1,505.3%
Financial Fact:
Net income attributable to Albemarle Corporation: 128.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +1,505.3%
Financial Fact:
Net income attributable to Albemarle Corporation: 128.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Albemarle (NYSE: ALB) reported Q2 EPS of $7.33, $2.60 better than the analyst estimate of $4.73. Revenue for the quarter came in at $2.4 billion versus the consensus estimate of $2.39 billion.
GUIDANCE:
Albemarle sees FY2023 EPS of $25.00-$29.50, versus the consensus of $23.31. Albemarle sees FY2023 revenue of $10.4-11.5 billion, versus the consensus of $10.12 billion.
For earnings history and earnings-related data on Albemarle (ALB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
